| Segment Reporting Disclosure [Text Block] |
13. Segment Information
Universal Biosensors, Inc. has one reportable segment: specialist biosensors company. The biosensors segment consists of the development, manufacture and commercialization of a range of point of use devices for measuring different analytes across different industries and the provision of testing services. The Company’s chief operating decision maker (“CODM”) is the Chief Executive Officer & Managing Director.
The accounting policies of the biosensors segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the biosensors segment based on net loss, which is reported on the income statement as net loss. The measure of segment assets is reported on the balance sheet as total assets.
To date, the Company has not generated significant revenue. The Company expects to continue to incur significant expenses and operating losses as our products mature in their various markets.
As such, the CODM uses revenue growth and cash forecast models in deciding how to invest into the biosensors segment. Such models are reviewed to assess the entity-wide operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment and in establishing management’s compensation, along with revenue growth and cash forecast models.
The table below summarizes the significant expense categories regularly reviewed by the CODM for the three and six months ended June 30, 2025 and 2024:
| |
|
Three Months Ended June 30,
|
|
|
Six Months Ended June 30,
|
|
| |
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
| |
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
Revenue from products & services
|
|
|
1,208,764 |
|
|
|
1,625,566 |
|
|
|
2,763,423 |
|
|
|
3,095,076 |
|
|
Cost of goods sold & services
|
|
|
2,415,458 |
|
|
|
455,251 |
|
|
|
3,126,773 |
|
|
|
1,046,895 |
|
|
Gross profit/(loss)
|
|
|
(1,206,694 |
) |
|
|
1,170,315 |
|
|
|
(363,350 |
) |
|
|
2,048,181 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses & income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounting, tax and audit
|
|
|
193,563 |
|
|
|
160,194 |
|
|
|
400,478 |
|
|
|
360,505 |
|
|
Depreciation & amortisation
|
|
|
174,767 |
|
|
|
222,609 |
|
|
|
325,410 |
|
|
|
475,707 |
|
|
Distribution, sales & marketing
|
|
|
114,301 |
|
|
|
58,713 |
|
|
|
251,141 |
|
|
|
513,716 |
|
|
Employee compensation
|
|
|
3,134,176 |
|
|
|
3,014,916 |
|
|
|
6,107,308 |
|
|
|
5,764,511 |
|
|
HRL operating expenses
|
|
|
431,334 |
|
|
|
416,175 |
|
|
|
697,458 |
|
|
|
794,360 |
|
|
Insurance
|
|
|
165,748 |
|
|
|
210,985 |
|
|
|
329,675 |
|
|
|
422,887 |
|
|
IT costs
|
|
|
233,231 |
|
|
|
146,106 |
|
|
|
412,274 |
|
|
|
273,487 |
|
|
Legal fees & consultancy
|
|
|
215,196 |
|
|
|
68,788 |
|
|
|
318,536 |
|
|
|
91,911 |
|
|
Occupancy expenses
|
|
|
132,970 |
|
|
|
98,003 |
|
|
|
276,218 |
|
|
|
219,866 |
|
|
Office administration
|
|
|
160,637 |
|
|
|
44,132 |
|
|
|
331,563 |
|
|
|
125,015 |
|
|
Other R&D expenses
|
|
|
283,444 |
|
|
|
3,525 |
|
|
|
579,661 |
|
|
|
257,742 |
|
|
Product registration & compliance
|
|
|
166,026 |
|
|
|
190,795 |
|
|
|
201,579 |
|
|
|
351,925 |
|
|
Sundry costs
|
|
|
270,993 |
|
|
|
902,137 |
|
|
|
520,461 |
|
|
|
316,588 |
|
|
Travel & conferences
|
|
|
120,877 |
|
|
|
209,985 |
|
|
|
212,070 |
|
|
|
297,694 |
|
|
Interest expense
|
|
|
507 |
|
|
|
6,660 |
|
|
|
2,743 |
|
|
|
13,347 |
|
|
Interest income
|
|
|
(16,458 |
) |
|
|
(126,905 |
) |
|
|
(79,849 |
) |
|
|
(195,561 |
) |
|
Research and development tax incentive income
|
|
|
(363,722 |
) |
|
|
(580,026 |
) |
|
|
(709,766 |
) |
|
|
(694,374 |
) |
|
Sundry income
|
|
|
(13,611 |
) |
|
|
(82,412 |
) |
|
|
(91,687 |
) |
|
|
(108,269 |
) |
|
Total operating expenses & income
|
|
|
5,403,979 |
|
|
|
4,964,379 |
|
|
|
10,085,273 |
|
|
|
9,281,056 |
|
|
Consolidated net loss
|
|
|
(6,610,674 |
) |
|
|
(3,794,064 |
) |
|
|
(10,448,624 |
) |
|
|
(7,232,875 |
) |
| |
|
Three Months Ended June 30,
|
|
|
Six Months Ended June 30, |
|
| |
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
| |
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
Research and development expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumables
|
|
|
24,485 |
|
|
|
474,101 |
|
|
|
277,549 |
|
|
|
31,454 |
|
|
Development costs
|
|
|
255,808 |
|
|
|
(15,052 |
) |
|
|
279,329 |
|
|
|
7,739 |
|
|
Employee compensation
|
|
|
1,191,651 |
|
|
|
730,293 |
|
|
|
1,499,636 |
|
|
|
1,257,034 |
|
|
Insurance
|
|
|
52,658 |
|
|
|
73,845 |
|
|
|
139,894 |
|
|
|
131,612 |
|
|
IT costs
|
|
|
37,952 |
|
|
|
14,199 |
|
|
|
52,111 |
|
|
|
26,195 |
|
| Office administration |
|
|
441,830 |
|
|
|
165,160 |
|
|
|
503,353 |
|
|
|
225,713 |
|
|
Travel & conference
|
|
|
365 |
|
|
|
220 |
|
|
|
19,454 |
|
|
|
1,479 |
|
|
Other
|
|
|
14,418 |
|
|
|
277,349 |
|
|
|
43,344 |
|
|
|
293,106 |
|
| |
|
|
2,019,167 |
|
|
|
1,720,116 |
|
|
|
2,814,670 |
|
|
|
1,974,333 |
|
| |
|
Three Months Ended June 30,
|
|
|
Six Months Ended June 30,
|
|
| |
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
| |
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
Selling, general & administrative expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounting, tax and audit
|
|
|
94,137 |
|
|
|
159,483 |
|
|
|
301,052 |
|
|
|
357,139 |
|
|
Consultancy
|
|
|
42,759 |
|
|
|
78,061 |
|
|
|
86,092 |
|
|
|
121,090 |
|
|
Cost of sales
|
|
|
336,394 |
|
|
|
123,961 |
|
|
|
442,693 |
|
|
|
264,052 |
|
|
Doubtful debts
|
|
|
77,345 |
|
|
|
32,556 |
|
|
|
99,177 |
|
|
|
32,556 |
|
|
Insurance
|
|
|
25,364 |
|
|
|
148,763 |
|
|
|
189,291 |
|
|
|
322,991 |
|
|
IT
|
|
|
205,556 |
|
|
|
155,452 |
|
|
|
384,599 |
|
|
|
268,773 |
|
|
Legal
|
|
|
144,028 |
|
|
|
53,986 |
|
|
|
247,369 |
|
|
|
90,415 |
|
|
Manufacturing costs
|
|
|
(123,119 |
) |
|
|
(158,182 |
) |
|
|
(87,565 |
) |
|
|
(58,318 |
) |
|
Occupancy
|
|
|
92,701 |
|
|
|
196,554 |
|
|
|
235,949 |
|
|
|
365,521 |
|
|
Regulatory
|
|
|
30,722 |
|
|
|
52,606 |
|
|
|
134,063 |
|
|
|
192,436 |
|
|
Sales & Marketing
|
|
|
171,388 |
|
|
|
249,355 |
|
|
|
334,737 |
|
|
|
395,164 |
|
|
Employee compensation
|
|
|
2,251,631 |
|
|
|
2,506,227 |
|
|
|
4,916,779 |
|
|
|
4,888,308 |
|
|
Travel
|
|
|
102,711 |
|
|
|
182,498 |
|
|
|
193,904 |
|
|
|
304,122 |
|
|
Other
|
|
|
(147,683 |
) |
|
|
(65,349 |
) |
|
|
190,768 |
|
|
|
197,104 |
|
| |
|
|
3,303,934 |
|
|
|
3,715,972 |
|
|
|
7,668,908 |
|
|
|
7,741,354 |
|
Our operations are in Australia, US, Europe and Canada. The chief operating decision maker of the Company is the Chief Executive Officer and the Managing Director.
The Company’s material long-lived assets are predominantly based in Australia and Canada.
|